Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8383
|
pubmed:dateCreated |
1984-5-30
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
28
|
pubmed:volume |
1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
963
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6143898-Adult,
pubmed-meshheading:6143898-Antipsychotic Agents,
pubmed-meshheading:6143898-Humans,
pubmed-meshheading:6143898-Hyponatremia,
pubmed-meshheading:6143898-Inappropriate ADH Syndrome,
pubmed-meshheading:6143898-Male,
pubmed-meshheading:6143898-Phenothiazines,
pubmed-meshheading:6143898-Schizophrenia, Paranoid
|
pubmed:year |
1984
|
pubmed:articleTitle |
Neuroleptic malignant syndrome and hyponatraemia.
|
pubmed:publicationType |
Letter,
Case Reports
|